The U.S. Centers for Disease Control and Prevention (CDC) will convene its vaccine advisory committee on June 25–26 for the first time since the panel was dissolved and reconstituted by…
The National Agency for Food and Drug Administration and Control (NAFDAC) has issued a public health alert over the circulation of an unregistered batch of Tarivid 200mg—a brand of the…
The Federal Government of Nigeria, in collaboration with the World Health Organization (WHO), has reiterated its commitment to a science-driven overhaul of the nation’s food safety framework, underscoring the urgent…
GSK has announced that the European Medicines Agency (EMA) is currently reviewing its application to expand the approved use of its respiratory syncytial virus (RSV) vaccine, Arexvy, to include adults…
The U.S. Food and Drug Administration (FDA) has granted expanded approval for Moderna’s respiratory syncytial virus (RSV) vaccine, mRESVIA, authorising its use in adults aged 18 to 59 who are…
European Union member states have endorsed a European Commission proposal to restrict Chinese medical device manufacturers from participating in EU public procurement tenders, following findings of systemic barriers faced by…
In a significant move to bolster global health security, 124 member states of the World Health Organization (WHO)voted in favor of a comprehensive international treaty aimed at strengthening pandemic preparedness…
Leading pharmaceutical companies are pushing back against U.S. President Donald Trump’s proposed global drug tariffs, warning that an abrupt implementation could disrupt medical supply chains, escalate compliance costs, and limit…
In a major advancement for rare disease treatment and regulatory medicine, the U.S. Food and Drug Administration (FDA) has approved the expanded use of Amgen’s Uplizna (inebilizumab) as the first…